Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30

Rhea-AI Summary

Pharming Group (Euronext: PHARM, Nasdaq: PHAR) will publish its preliminary, unaudited financial results for the second quarter and first half of 2026 and provide a business update on Thursday, July 30, 2026. On the same day, management will host a conference call and live webcast for analysts and investors at 13:30 CEST / 07:30 EDT. Participants must register in advance via the provided conference call and webcast links; dial-in attendees will be able to ask questions. The live webcast and subsequent replay will be accessible through Pharming’s website under Investors/Financial Documents & Reports.

Key Figures

Earnings release date: July 30, 2026 Conference call time: 13:30 CEST / 07:30 am EDT

2 metrics

Earnings release date July 30, 2026 Preliminary unaudited 2Q26 and 1H26 results

Conference call time 13:30 CEST / 07:30 am EDT Management call on earnings release day

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Leiden, the Netherlands, July 16, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second quarter and first half 2026 and provide a business update on Thursday, July 30, 2026.

Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CEST/07:30 am EDT.

To participate in the conference call or to watch the live webcast, please register in advance using the links below.

Conference call registration:
https://register-conf.media-server.com/register/BId285845cff504c39931913d279f646ea

Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.

Please note, the Company will only take questions from dial-in attendees.

Webcast registration:
https://edge.media-server.com/mmc/p/m35zejc7

The webcast will also be accessible on the Pharming website at Investors/Financial Documents & Reports, and a replay will be available shortly after the event.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We develop and commercialize innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with U.S. and European operations.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming
Michael Levitan, VP Investor Relations and Capital Markets
T: +1 (908) 705 1696
E: investor@pharming.com

Saskia Mehring, Head of Corporate Communications
T: +31 6 28 32 60 41
E: media.relations@pharming.com

Media Relations
Julia Deutsch (Lyra Strategic Advisory on behalf of Pharming)
E: jdeutsch@lyraadvisory.com

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

Attachment

• Pharming Group to report 2Q_1H26 results_EN_16JULY2026

FAQ

When will Pharming Group (PHARM) release its Q2 and H1 2026 financial results?

Pharming Group plans to release its preliminary, unaudited Q2 and H1 2026 results on Thursday, July 30, 2026. According to Pharming, the announcement will be accompanied by a business update for analysts and investors on the same day.

What time is Pharming Group’s Q2 2026 earnings conference call and webcast on July 30, 2026?

The Q2 and H1 2026 conference call and webcast are scheduled for 13:30 CEST / 07:30 EDT on July 30, 2026. According to Pharming, management will present results and a business update during this event.

How can investors register for Pharming Group’s PHARM Q2 2026 conference call?

Investors can register for the conference call via Pharming’s specified registration link, which then provides dial-in details and a unique PIN. According to Pharming, only dial-in participants will be able to ask questions during the call.

Where can I watch the Pharming Group (PHARM) Q2 and H1 2026 results webcast?

The live webcast is accessible through Pharming’s webcast registration link and via its website under Investors/Financial Documents & Reports. According to Pharming, a replay of the webcast will also be made available shortly after the event.

Will a replay be available for Pharming Group’s July 30, 2026 financial results webcast?

Yes, a replay of the Q2 and H1 2026 webcast will be available shortly after the event. According to Pharming, investors can access this replay via the company’s website in the Investors/Financial Documents & Reports section.

Are Pharming Group’s Q2 and H1 2026 results on July 30, 2026 audited or preliminary?

The Q2 and H1 2026 figures to be reported on July 30, 2026 are preliminary and unaudited. According to Pharming, these initial results will be presented alongside a broader business update for stakeholders.